Concurrent Ki-67 and p53 Immunolabeling in Cutaneous Melanocytic Neoplasms: An Adjunct for Recognition of the Vertical Growth Phase in Malignant Melanomas?
- 1 March 2000
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 13 (3), 217-222
- https://doi.org/10.1038/modpathol.3880040
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunohistologic Evaluation of Putatively Mutant p53 Protein in Cutaneous Melanocytic NeoplasmsInternational Journal of Surgical Pathology, 1998
- MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanomaJournal of the American Academy of Dermatology, 1996
- Nuclear morphometry, immunohistochemical staining with Ki‐67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skinJournal of Cutaneous Pathology, 1996
- Proliferating cell nuclear antigen staining in deep-penetrating neviJournal of the American Academy of Dermatology, 1995
- Expression of proliferating cell nuclear antigen in Spitz nevusJournal of the American Academy of Dermatology, 1995
- p53 gene mutation and expression in naevi and melanomasMelanoma Research, 1995
- Nucleolar Organizer Regions (AgNOR) and Ki-67 Immunoreactivity in Cutaneous Melanocytic LesionsThe American Journal of Dermatopathology, 1995
- Morphometric, DNA, and Proliferating Cell Nuclear Antigen Measurements in Benign Melanocytic Lesions and Cutaneous Malignant MelanomaThe American Journal of Dermatopathology, 1994
- Malignant Melanoma within an Intradermal NevusThe American Journal of Dermatopathology, 1994
- Proliferative Activity of Cutaneous Melanocytic Tumors Defined by Ki-67 Monoclonal AntibodyThe American Journal of Dermatopathology, 1989